Ionis Pharmaceuticals, Inc. – LSE:0JDI.L
Ionis Pharmaceuticals stock price today
Ionis Pharmaceuticals stock price monthly change
Ionis Pharmaceuticals stock price quarterly change
Ionis Pharmaceuticals stock price yearly change
Ionis Pharmaceuticals key metrics
Market Cap | 5.69B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.66 |
Revenue | 776.00M |
EBITDA | -327.53M |
Income | -384.06M |
Revenue Q/Q | -8.78% |
Revenue Y/Y | 34.59% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -42.21% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIonis Pharmaceuticals stock price history
Ionis Pharmaceuticals stock forecast
Ionis Pharmaceuticals financial statements
| Jun 2023 | 188M | -85M | -45.21% |
|---|---|---|---|
| Sep 2023 | 144M | -147M | -102.08% |
| Dec 2023 | 324.50M | -9.26M | -2.85% |
| Mar 2024 | 119.49M | -142.80M | -119.5% |
| Dec 2023 | 324.50M | -9.26M | -2.85% |
|---|---|---|---|
| Mar 2024 | 119.49M | -142.80M | -119.5% |
| Sep 2025 | 170.25M | -149.88M | -88.03% |
| Dec 2025 | 198.03M | -134.32M | -67.83% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 2971000000 | 2.54B | 85.59% |
|---|---|---|---|
| Sep 2023 | 2934000000 | 2.61B | 89.26% |
| Dec 2023 | 2990072000 | 2.60B | 87.07% |
| Mar 2024 | 2763928000 | 2.46B | 89.27% |
| Jun 2023 | -97.36M | 69.51M | 143.53M |
|---|---|---|---|
| Sep 2023 | -109.02M | 68.71M | -32.26M |
| Dec 2023 | 32.86M | -26.71M | 40.72M |
| Mar 2024 | -149.93M | 76.10M | 23.57M |
Ionis Pharmaceuticals alternative data
| Aug 2023 | 796 |
|---|---|
| Sep 2023 | 796 |
| Oct 2023 | 796 |
| Nov 2023 | 796 |
| Dec 2023 | 796 |
| Jan 2024 | 796 |
| Feb 2024 | 796 |
| Mar 2024 | 927 |
| Apr 2024 | 927 |
| May 2024 | 927 |
| Jun 2024 | 927 |
| Jul 2024 | 927 |
Ionis Pharmaceuticals other data
| Patent |
|---|
Grant Filling date: 18 Nov 2021 Issue date: 20 Sep 2022 |
Grant Filling date: 9 May 2019 Issue date: 6 Sep 2022 |
Application Filling date: 13 Feb 2020 Issue date: 1 Sep 2022 |
Application Filling date: 20 Dec 2019 Issue date: 1 Sep 2022 |
Grant Utility: Modulation of Huntington expression Filling date: 12 Oct 2020 Issue date: 23 Aug 2022 |
Grant Filling date: 29 Jun 2016 Issue date: 16 Aug 2022 |
Application Filling date: 15 May 2020 Issue date: 11 Aug 2022 |
Application Filling date: 8 Feb 2022 Issue date: 4 Aug 2022 |
Application Filling date: 17 Dec 2021 Issue date: 4 Aug 2022 |
Application Filling date: 22 Sep 2021 Issue date: 4 Aug 2022 |
| Insider | Compensation |
|---|---|
| Dr. Stanley T. Crooke (1945) Founder & Executive Chairman | $1,970,000 |
| Ms. B. Lynne Parshall (1954) Senior Strategic Advisor & Director | $1,360,000 |
| Dr. Brett P. Monia (1961) Founder, Chief Executive Officer & Director | $1,060,000 |
| Ms. Elizabeth L. Hougen (1962) Executive Vice President of Fin. & Chief Financial Officer | $834,190 |
| Dr. Richard S. Geary (1958) Executive Vice President of Devel. | $829,790 |
| Mr. Patrick R. O'Neil (1974) Executive Vice President of Legal, Gen. Counsel, Chief Compliance Officer & Corporation Sec. | $816,230 |
Mr. Darren Gonzales Chief Accounting Officer & Senior Vice President | |
| Dr. C. Frank Bennett Executive Vice President & Chief Scientific Officer | |
Mr. D. Wade Walke Vice President of Investor Relations | |
Ms. Roslyn Patterson M.B.A. Vice President of Marketing & Communications |
-
What's the price of Ionis Pharmaceuticals stock today?
One share of Ionis Pharmaceuticals stock can currently be purchased for approximately $43.23.
-
When is Ionis Pharmaceuticals's next earnings date?
Unfortunately, Ionis Pharmaceuticals's (0JDI.L) next earnings date is currently unknown.
-
Does Ionis Pharmaceuticals pay dividends?
No, Ionis Pharmaceuticals does not pay dividends.
-
How much money does Ionis Pharmaceuticals make?
Ionis Pharmaceuticals has a market capitalization of 5.69B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34.18% to 787.65M US dollars.
-
What is Ionis Pharmaceuticals's stock symbol?
Ionis Pharmaceuticals, Inc. is traded on the LSE under the ticker symbol "0JDI.L".
-
What is Ionis Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Ionis Pharmaceuticals?
Shares of Ionis Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Ionis Pharmaceuticals's key executives?
Ionis Pharmaceuticals's management team includes the following people:
- Dr. Stanley T. Crooke Founder & Executive Chairman(age: 80, pay: $1,970,000)
- Ms. B. Lynne Parshall Senior Strategic Advisor & Director(age: 71, pay: $1,360,000)
- Dr. Brett P. Monia Founder, Chief Executive Officer & Director(age: 64, pay: $1,060,000)
- Ms. Elizabeth L. Hougen Executive Vice President of Fin. & Chief Financial Officer(age: 63, pay: $834,190)
- Dr. Richard S. Geary Executive Vice President of Devel.(age: 67, pay: $829,790)
- Mr. Patrick R. O'Neil Executive Vice President of Legal, Gen. Counsel, Chief Compliance Officer & Corporation Sec.(age: 51, pay: $816,230)
- Mr. Darren Gonzales Chief Accounting Officer & Senior Vice President
- Dr. C. Frank Bennett Executive Vice President & Chief Scientific Officer
- Mr. D. Wade Walke Vice President of Investor Relations
- Ms. Roslyn Patterson M.B.A. Vice President of Marketing & Communications
-
Is Ionis Pharmaceuticals founder-led company?
Yes, Ionis Pharmaceuticals is a company led by its founders Dr. Stanley T. Crooke and Dr. Brett P. Monia.
-
How many employees does Ionis Pharmaceuticals have?
As Jul 2024, Ionis Pharmaceuticals employs 927 workers.
-
When Ionis Pharmaceuticals went public?
Ionis Pharmaceuticals, Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is Ionis Pharmaceuticals's official website?
The official website for Ionis Pharmaceuticals is ionispharma.com.
-
Where are Ionis Pharmaceuticals's headquarters?
Ionis Pharmaceuticals is headquartered at 2855 Gazelle Court, Carlsbad, CA.
-
How can i contact Ionis Pharmaceuticals?
Ionis Pharmaceuticals's mailing address is 2855 Gazelle Court, Carlsbad, CA and company can be reached via phone at +7 609319200.
Ionis Pharmaceuticals company profile:
Ionis Pharmaceuticals, Inc.
ionispharma.comLSE
927
Medical - Pharmaceuticals
Healthcare
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
Carlsbad, CA 92010
:
ISIN: US4622221004
:
